Chugai Pharmaceutical Co. Ltd.

05/13/2025 | Press release | Archived content

エレビジス、デュシェンヌ型筋ジストロフィーに対する遺伝子治療用製品として、日本で製造販売承認を取得

Chugai Pharmaceutical Co. Ltd. published this content on May 13, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 11, 2025 at 09:08 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io